Search Immortality Topics:

Page 21234..1020..»


Category Archives: Anti-Aging Medicine

COVID-19 the new disease of growing old, hastening the work of anti-aging scientists – National Post

Our success in delaying death in late life made us vulnerable to COVID-19 mortality. Photo by Carlos Osorio/Reuters

Underlying the research are some cold, hard facts about human biology. Evolution, it seems, has ensured humans live healthily long enough to reproduce and look after their offspring until they become independent.

That translates into an average biological warranty period of about 70 years, the time before which the body begins to undermine itself, increasing the risk of disease and frailty, says Farrelly. So as weve learned to at least manage diseases of old-age and get people to live longer, the result is often years of illness and disability at the end of life, he said.

But thats not to say that growing old and weak in the way we expect is written in stone.

Theres no law of physics or law of the universe that says that aging has to occur, said Austad. Living organisms are almost definable by their ability to repair themselves Aging is the ultimate failure of repair. (But) that doesnt mean its not possible to intervene in the system.

Such intervention would not necessarily extend lifespans, but ideally make the later years healthier and more productive, a major advance in itself.

That would change the nature of human existence incredibly, said Austad. If you had another 10 to 20 years of healthy life to look forward to, that might influence almost everything you did when you went to school, when you had kids, how many careers you had.

Rapamycin may be the most promising of possible anti-aging treatments.

See the original post here:
COVID-19 the new disease of growing old, hastening the work of anti-aging scientists - National Post

Posted in Anti-Aging Medicine | Comments Off on COVID-19 the new disease of growing old, hastening the work of anti-aging scientists – National Post

Board-Certified Dermatologist and Baylor Professor: Has the Pandemic Accelerated Aging Skin? – Newswise

While 2020 may have felt like the longest year, unfortunately, there is one aspect of the pandemic that may have been accelerated aging skin.

According to board-certified dermatologist Rajani Katta, MD, FAAD, clinical assistant professor at the Baylor College of Medicine, a combination of factors brought on by the pandemic are contributing to growing complaints of accelerated skin aging.

Some of this has to do with perception and what I call Zoom face. Between the poor lighting, harsh shadows and strange angles in which were seeing ourselves on camera, its the equivalent of looking at our face for hours in an unflattering mirror, said Dr. Katta. In addition to more video calls, the pandemic has ushered in many sleepless nights and increased stress levels, which we know can contribute to premature skin aging.

Dr. Katta is also seeing more patients who are experimenting with at-home treatments like peels and masks that can cause redness, irritation and flaking skin, which can make your skin appear older. Some patients who are experiencing skin irritation from wearing a face mask have had to stop using effective anti-aging products altogether during the pandemic. Finally, lifestyle changes that include less exercise and more unhealthy eating have contributed to accelerated skin aging.

Dr. Katta is available to discuss additional insights on how the pandemic is impacting peoples skin and offers these tips to her patients.

Five tips for combating aging skin during the pandemic:

###

More Information

11 ways to reduce premature skin aging

Anti-aging skin care

Age spots and dark marks

Skin care in your 40s and 50s

How to maintain younger-looking skin

How to treat wrinkles

How to treat scars and stretch marks

Original post:
Board-Certified Dermatologist and Baylor Professor: Has the Pandemic Accelerated Aging Skin? - Newswise

Posted in Anti-Aging Medicine | Comments Off on Board-Certified Dermatologist and Baylor Professor: Has the Pandemic Accelerated Aging Skin? – Newswise

Mental Health Took A Hit In 2020 – Anti Aging News

According to a recent survey of 2,000 American adults, 1 in 6 started therapy for the first time during 2020, adding to the 31% of Americans who are already attending therapy or returning to therapy that year.

Respondents reported several reasons for seeking therapy, including 45% confirming that the recent outbreak of COVID-19 was the main driving reason that prompted them to start counseling, with only 15% saying that the current global public health issue did not damage their state of mental health. 15% of respondents began taking medication for mental health issues for the first time in 2020, and another 15% changed or increased their prescription dosages.

88% of respondents report at least one symptom that is indicative of mental health trauma, and 68% reported saying that they feel like they are defeated going into 2021 with 63% saying that that pandemic is to blame.

47% reported that they believed that entering therapy was a sign of weakness, but that is not true, seeking help for overwhelming anxiety, depression, stress or another mental challenge is a sign of strength, and it is a necessity for many during the imposed lockdowns and restrictions.

Americans often place other priorities above their own mental health needs, not just because of stigma but because of time. They often see work, home and social responsibilities as being more important than their personal health and well-being. But just as they tell you on airplanes when the oxygen masks come down, we cant help others if we dont take care ourselves first, said Chris Mosunic, Ph.D., and chief clinical officer at Vida Health.

The bottom line is that there are many ways to improve your mental well being, he added. You just have to choose a path you feel comfortable with and can take ownership of.

59% report being more interested in mindfulness now than they were pre-COVID, and 60% report feeling more aware of and in touch with their emotions than ever before. The most popular forms of therapy were: 40% preferring both virtual and in-person therapy, 38% reporting counseling, 35% talk therapy, 27% cognitive-behavioral therapy, 25% text therapy, 22% psychodynamic therapy, 20% dialectical behavioral therapy, 18% humanistic therapy, and 17% reporting couples therapy.

Results come as no surprise as around the world many people are battling their own personal crisis as a result of the pandemic and the accompanying mandates and restrictions influencing everything from jobs/finances and shopping to interactions with family members and close friends causing physical separation, emotional anxiety, and mental exhaustion.

Winter months can be difficult for many due to seasonal affective disorder, add the restrictions and mandates to this and a sizable portion of the population is struggling with mental health during a winter unlike any other in recent memory. 62% of the respondents report feeling more depressed during the winter, and 32% winter as being the worst season for their mental health.

Symptoms of SAD can include but are not limited to oversleeping, intense cravings for carbs, overeating, gaining weight, trouble concentrating, withdrawing socially, and avoiding engaging in typical daily activities. If any of these seems familiar light therapy may help to give your mood a needed boost, and it can help to increase your vitamin D levels which is helpful in treating SAD as well as giving a boost to your immune system to help ward off infectious diseases during these darker months.

88% of respondents reported having symptoms of mental health trauma including 52% reporting little to no pleasure in doing things, 52% having trouble falling or staying asleep, and 51% feeling down, depressed or hopeless. High levels of depression, anxiety, and PTSD were also reported among young American adults aged 18-30 years old. Another research team is looking into the psychosocial impacts of this outbreak.

Disease itself multiplied by forced quarantine to combat COVID-19 applied by nationwide lockdowns can produce acute panic, anxiety, obsessive behaviors, hoarding, paranoia, and depression, and post-traumatic stress disorder (PTSD) in the long run.

Most experts can agree that disruptions to traditional grief rituals including the ability to say goodbye and viewing/burial of a loved one are likely to increase symptoms of prolonged grief disorder. To add to this being forced to go through the loss and grieving process in imposed social isolation without the benefits and comfort of long-held bereavement rituals is a recipe for a psychiatric pandemic, according to the research from the Iran University of Medical Sciences.

The researchers from the Iran University of Medical Sciences are among many who are trying to highlight the fact that the prolonged imposed restrictions and mandates are increasing the very real likelihood of PGD making an already difficult life event even harder to process. The profound disruptions can compound mental health challenges and lead to a cycle of unresolved bereavement, depression, and PTSD as humans are being robbed of their ability to participate in compassionate age-old bereavement rituals.

Millions of people around the world have experienced the loss of a loved one due to the Coronavirus Disease 2019 (COVID-19) pandemic. Given the restrictive lockdown regulations and stay-at-home orders, most of these individuals did not get a chance to say goodbye to their loved ones, properly to have a funeral/ceremony for their loss or to bury them.

As a result, millions of individuals have not experienced a regular grief cycle that enables individuals to rapidly adjust to the situation and recover themselves.

Alarmingly 68% of the respondents reported feeling defeated going into 2021, with 63% saying that the outbreak has taken the wind out of their sails, 45% reporting not being able to enjoy pre-COVID activities; and 45% being deflated by the election, 35% by the spread of misinformation, and 30% being deflated by the 24/7 news cycle.

Drastic changes have taken place during the past year, with it many have been neglecting their own personal health, with over half of the respondents saying that they feel too overwhelmed to make their health a priority and 56% reporting that they are struggling to find an effective wellness routine.

Another stress survey from The American Psychological Association revealed similar findings; high levels of stress-related to coronavirus are common for parents, while people of color are more likely than white adults to report the outbreak was causing significant stress in their lives, in particular fears of becoming infected and having access to basic needs and healthcare services.

Some estimates predict that up to 75,000 people may die from drug or alcohol misuse and suicide during this pandemic, according to a report by the Well Being Trust and the Robert Graham Center for Policy Studies in Family Medicine and Primary Care. These kinds of deaths are called deaths of despair, and they are expected to be exacerbated by three factors at play; the unprecedented economic failure paired with massive unemployment, the mandated social isolation for prolonged months and possible residual isolation for years, and the uncertainty that was caused by the sudden emergence of a novel microbe.

Although it will not be fully clear of the full mental health fallout from this pandemic for years, it has already been discovered that the prevalence of depression symptoms has increased by more than threefold going from 8.5% pre-COVID to 27.8% during the outbreak. Exposure to a greater number of stressors was associated with an increased risk of depression, as well as having a lower income and having less than $5,000 in saving during the pandemic with the latter being associated with a 1.5 fold increase in the risk of depression representing a 50% greater risk of depression symptoms. The prolonged social distancing and isolation are only exacerbating the problem with social isolation increasing the likelihood of mortality by 29% and loneliness increasing it by 26%.

According to a review published in The Lancet investigating the psychological impact of quarantine, Most reviewed studies reported negative psychological effects including post-traumatic stress symptoms, confusion and anger. out of 2,760 quarantine people, 34& experienced high levels of psychological distress which could include depression. A number of stressors during quarantines were noted including: longer quarantine duration, infection fears, frustration, boredom, inadequate supplies, inadequate information, financial loss, and stigma.

During this trying time, it is important not to ignore your mental health and try your best to maintain positive habits. Physical exercise has been shown to act as a natural antidepressant, a quick search online can provide a variety of different free workouts to follow along with online that you can do at home ranging from yoga and tai chi to HIIT and Crossfit to Zumba and dance fitness. Going outside for a walk in nature can also be mentally soothing. Reach out to friends and family if you are feeling isolated. Releasing negative emotions of feelings of stress and anxiety that are directly related to the outbreak is recommended.

Emotional Freedom Techniques have been developed to help those facing PTSD or other serious mental health challenges that can be done anywhere in only a few minutes. For general anxiety, stress, and uneasiness related to trying times it may be worth looking into the mechanics of EFT to learn more about the wide-ranging application for better mental health. Click here to read the study Clinical EFT (Emotional Freedom Techniques) Improves Multiple Physiological Markers of Health published in PMC concluding that Reviews and meta-analyses of EFT demonstrate that it is an evidence-based practice and that its efficacy for anxiety, depression, phobias, and PTSD is well-established. The research investigating physiological improvements after EFT intervention is limited; however, this study adds to the body of literature and suggests that EFT is associated with multidimensional improvements across a spectrum of physiological systems.

This pandemic and related mandates/restrictions are taking a stressful toll, if you or someone that you know is struggling mentally or emotionally, please seek help from a therapist, daily exercise might help, and you can try to connect with loved ones even if it is via live video, and by utilizing the Emotional Freedom Techniques. Cognitive-behavioral therapy may help, as well as mindfulness techniques and antidepressants to help reduce your risk of depression. You do not have to struggle alone.

SAMHSA National Helpline= 1-800-622-HELP(4357)

National Suicide Prevention Lifeline= 1-800-273-TALK(8255)

Crisis Text HotLine= Text HELLO to 741741

The Samaritans Emotional Support=1-877-870-HOPE(4673)

Disaster Distress Helpline= 1-800-985-5590

Read the original post:
Mental Health Took A Hit In 2020 - Anti Aging News

Posted in Anti-Aging Medicine | Comments Off on Mental Health Took A Hit In 2020 – Anti Aging News

Global Energy-Based Therapeutics Market 2020 Disclosing Latest Trends and Advancement Outlook 2026 Along With Covid-19 Impact Analysis KSU | The…

DBMR has added a new report titled Global Energy-Based Therapeutics Market with analysis provides the insights which bring marketplace clearly into the focus and thus help organizations make better decisions. This report covers the present scenario and the growth prospects of the global market and includes a discussion of the key vendors operating in the market. It intends to supply an entire 360-degree perspective of this market concerning cutting edge technology, key advancement, drivers and restraints and prospective trends with impact analysis. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risk and entry barriers. This Global Energy-Based Therapeutics Market report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market.

This Global Energy-Based Therapeutics Market report provides a valuable source of insightful for business strategists and competitive analysis of the global market. It provides industry overview with the growth analysis and futuristic cost. This Global Energy-Based Therapeutics Market research report guides you to overcome the upcoming obstacles in the business. Various Analytic tools like SWOT analysis, Porters five force analysis, PESTLE Analysis are utilized to gain the relevant information of the market. In the end, Report provides a comprehensive data which enhances the understanding, scope and application of the report.

Global Energy-Based Therapeutics Market, By Product Type (Microwave, Radiofrequency, Hydro-Mechanical, Cryotherapy, Thermal and Ultrasound), Clinical Application (Aesthetic, Surgical and Ophthalmic), End-User (Hospital, Clinics and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027

Market Analysis and Insights : Global Energy-Based Therapeutics Market

Energy-based therapeutics market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to grow at a CAGR of 6.00% in the above-mentioned forecast period. Invent of laser based therapies insurgicalprocedures will drive the growth of the market.

Download Exclusive Sample Report (350 Pages PDF with All Related Graphs & Charts) @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-energy-based-therapeutics-market&pm

The major players covered in the energy-based therapeutics market report are Johnson and Johnson Surgical Vision, Inc, AngioDynamics, Inc, Alna-Medicalsystem AG and Co.KG, Alcon Management S.A, AtriCure,Inc, Symmetry Surgical, Boston Scientific Corporation, biolitec AG, Cutera, Inc, Cynosure, Dornier MedTech, INSIGHTEC Ltd, EDAP TMS, IRIDEX Corporation, LIGHTMED, Mederi Therapeutics Inc, Medtronic plc, NIDEk CO,LTD, Optos plc.UWF, among other domestic and global players.

Competitive Landscapeand Global Energy-Based Therapeutics Market Share Analysis

Energy-based therapeutics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies focus related energy-based therapeutics market.

Energy-based therapeutics are done for the destruction and modification of tissues with the help of technologies such as hydro-mechanical, cryotherapy, ultrasound, microwave and thermal.

In aesthetic medicine have led to an increase in the adoption of anti-aging treatments and energy-based aesthetic surgeries, energy-based therapeutics are affordable and effective and shift of invasive to non-invasive aesthetic procedures on global level due to this reason has driven the growth of the market. Increased number of population for minimal invasive surgeries for the treatment of cancer, tumors, cardiac arrhythmias and other diseases with the benefits associated with these procedures such as creating a positive outlook and reduced complications for the global energy based therapeutic market are factors driving the growth of the market. Rising trend of physician owned ambulatory surgical centres known as ASCs is a key factor for the growth of the market and will create growth opportunities in energy-based therapeutics market the forecast period of 2020-2027.

Varied regulations for medical devices will act as a restrain, and further challenges the growth of energy-based therapeutics market forecast period mentioned above.

This energy-based therapeutics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research energy-based therapeutics market contact us for anAnalyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Energy-Based Therapeutics Market Scope and Market Size

Energy-based therapeutics market is segmented on the basis of clinical application, end-user and product type. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Table of Contents-Snapshot

Executive SummaryChapter 1 Industry OverviewChapter 2 Industry Competition by ManufacturersChapter 3 Industry Production Market Share by RegionsChapter 4 Industry Consumption by RegionsChapter 5 Industry Production, Revenue, Price Trend by TypeChapter 6 Industry Analysis by ApplicationsChapter 7 Company Profiles and Key Figures in Industry BusinessChapter 8 Industry Manufacturing Cost AnalysisChapter 9 Marketing Channel, Distributors and CustomersChapter 10 Market DynamicsChapter 11 Industry ForecastChapter 12 Research Findings and ConclusionChapter 13 Methodology and Data Source

For More Insights Get FREE Detailed TOC @https://www.databridgemarketresearch.com/toc/?dbmr=global-energy-based-therapeutics-market&pm

Global Energy-Based Therapeutics Market Country Level Analysis

Energy-based therapeutics market is analysed and market size insights and trends are provided by country, clinical application, end-user and product type as referenced above.

The countries covered in the energy-based therapeutics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is dominating the energy-based therapeutics market due to its well established healthcare infrastructure. As growing preference for minimally invasive surgeries in this region are responsible for the growth of the market in the region.

The country section of the energy-based therapeutics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Energy-based therapeutics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipments, installed base of different kind of products for energy-based therapeutics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the energy-based therapeutics market. The data is available for historic period 2010 to 2018.

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @Corporatesales@databridgemarketresearch.com

The rest is here:
Global Energy-Based Therapeutics Market 2020 Disclosing Latest Trends and Advancement Outlook 2026 Along With Covid-19 Impact Analysis KSU | The...

Posted in Anti-Aging Medicine | Comments Off on Global Energy-Based Therapeutics Market 2020 Disclosing Latest Trends and Advancement Outlook 2026 Along With Covid-19 Impact Analysis KSU | The…

GNT Pharma’s GedaCure Approved for the Treatment of Dogs With Cognitive Dysfunction Syndrome – Business Wire

YONGIN, South Korea--(BUSINESS WIRE)--GNT Pharma today announced the Korea Animal and Plant Quarantine Agency (APQA) has approved the New Drug Application for GedaCure, a chewable tablet of crisdesalazine, for the treatment of dogs with cognitive dysfunction syndrome (CDS) that suffer from disorientation, altered interactions with family, sleep-wake cycle disturbance, house soiling and changes in activity with aging.

GedaCure is the worlds first multi-target neuroprotection drug for canine cognitive dysfunction syndrome. It is expected to improve the quality of life of aged dogs with CDS and their owners. GNT Pharma plans to launch GedaCure in South Korea and will push ahead in earnest to advance globally for dogs and their family who suffer from CDS.

Like Alzheimers disease (AD), canine CDS is an age-related progressive neurodegenerative disease with a cognitive and behavioral deficit that is accompanied by beta amyloid precipitation, pathological tau, and neuronal death. The prevalence of senior dogs with CDS has been rapidly increasing with the extended lifespan, however, there is no cure for the disease.

Crisdesalazine prevents oxidative stress as a spin trapping agent and inflammation as an inhibitor of microsomal prostaglandin E synthase-1 (mPGES-1), inducible enzymes essential for inflammatory PGE2 production. Crisdesalazine showed considerable effects in 3-D culture and animal models of Alzheimers disease in reducing neuronal death, tauopathy, and amyloid plaques to some extent which are pathological hallmarks of Alzheimers disease.

In a pilot clinical trial for canine CDS, all 6 companion dogs with CDS that received daily oral administration of 10 mg/kg crisdesalazine for 8 weeks showed remarkable symptomatic relief. Even in 4 weeks after administration of crisdesalazine, the dogs re-recognized and wagged their tails to their owners, slept well in the night, and revealed improved activity.

GNT Pharma conducted a double-blind, randomized, placebo-controlled phase III SMART trial of crisdesalazine for 48 companion dogs with CDS at 6 animal hospitals including Seoul National University Animal Hospital. All dogs were diagnosed as CDS according to canine cognitive dysfunction rating scale (CCDR score: 0-39 = normal, 40-49 = at risk, 50-80 = CDS). Baseline scores of CCDR before drug treatment were 61.7 2.8 for the placebo group and 62.2 2.3 for the crisdesalazine group. CCDR scores were 60.7 2.7 and 65.0 3.9 after 4-week and 8-week treatment with placebo. CCDR scores were reduced to 43.0 2.9 and 42.1 4.0 after 4-week and 8-week treatment with 5 mg/kg crisdesalazine, demonstrating significant beneficial effects of crisdesalazine vs placebo (p<0.0001). Similar beneficial effects were observed in companion dogs with CDS treated with 10 mg/kg crisdesalazine. Such beneficial effects lasted over at least 4 weeks after discontinuing 8-week treatment with crisdesalazine. Drug-related adverse events were not observed.

Administration of crisdesalazine significantly and noticeably improved cognitive function and behavioral activity without causing adverse effects in dogs with CDS that participated in the SMART trial. With rapidly increasing population of aged dogs, CCDS has been one of therapeutic areas with the highest unmet medical need. In light of proven efficacy and safety, crisdesalazine is expected to improve the quality of life of aged dogs with CDS and their owners, said Hwa-Young Youn, D.V.M. and Ph.D., Professor of Veterinary Medicine at Seoul National University, Principal Investigator of SMART trial.

We are excited to receive a new drug approval for the treatment of old dogs with CDS. The novel dual antioxidant and anti-inflammatory action of crisdesalazine, which was shown to reduce amyloid plaque, tauopathy, and neurodegeneration in various cell culture and animal models, has the potential to revolutionize how we care for CDS, said Byoung Joo Gwag, Ph.D., GNT Pharmas President and CEO, Adjunct Professor of Biological Sciences at Yonsei University. Crisdesalazine, the first multi-target drug proven and approved for CDS featuring brain pathology similar to AD, gives hope for better treatment of AD patients. We plan to initiate a pivotal clinical trial of crisdesalazine for patients with mild to moderate AD this year.

View post:
GNT Pharma's GedaCure Approved for the Treatment of Dogs With Cognitive Dysfunction Syndrome - Business Wire

Posted in Anti-Aging Medicine | Comments Off on GNT Pharma’s GedaCure Approved for the Treatment of Dogs With Cognitive Dysfunction Syndrome – Business Wire

In The Know Honors: Shereen Pimentel – Yahoo Canada Shine On

Eat This, Not That!

Sugar is hard to escape in the American diet. It's in everything from condiments to juices to bread. And yes, even in those McDonald's fries. And Americans are eating a lot of it."Today, the average American consumes almost 17 teaspoons of added sugar a day, according to researchers at the University of California San Francisco," says Sue Heikkinen, MS, RD, registered dietitian for MyNetDiary. One in four Americans far exceeds the USDA's recommended daily added sugar cap of 50 grams, instead consuming a staggering 105 grams of added sugar per day. (The American Heart Association guidelines suggest no more than 24 grams of added sugar for women and no more than 35 grams for men.)Most of that sugar comes from drinks. "Sugar-sweetened beverages, such as soda, energy drinks, and sweetened tea are the leading source of added sugarproviding 47% of added sugar in the U.S. diet," says Heikkinen. "There is some encouraging newsthis added sugar intake represents a decrease from earlier reports."Eat a diet high in sugar, and the impact may not be seen until later."Many of the side effects of excess sugar consumption aren't immediate, but instead build up over years," says Elizabeth Spencer, MS, RDN, LDN, registered dietitian at Northwestern Medicine Central DuPage Hospital. "These include risk of Type 2 diabetes, fatty liver, heart disease, and inflammation of the joints."Excessive intake of added sugar can lead to various health issues such as weight gain, inflammation, and diabetes, so you'll want to look out for the signs you're overdoing it before it gets any worse.One of the biggest danger signs that you're eating too much sugar is that you're constantly feeling both anxious and tired.Sugar is our body's main source of energy, so it's somewhat ironic that eating too much of the stuff can cause us to feel tired. "Eating sugary foods can indeed give an energy boost, but it can result in a crash later," says Heikkinen. "This can set up a vicious cycle of turning to sugar again for a quick energy, then feeling fatigued again later. Fatigue can also be a symptom of high blood sugar (caused by eating too much sugar)."Spencer explains that eating too much sugar at one time can cause jiteriness, but the fatigue will come quickly afterwards. "Eating a high sugar food can raise the amount of sugar in our bloodstream very quickly and provide a quick burst of energy, as well as feelings of anxiety and jitteriness," says Spencer. "When we have an excess amount of sugar in our bloodstream, our body rapidly produces the hormone insulin to usher the sugar into our cells. This can then cause a sugar crash from decreased sugar in our bloodstream, resulting in that midafternoon slump and low energy."This crashing sensation won't just drain your energy at certain times of the day, it may even go so far as to disrupt a good night's sleep."Consuming large amounts of sugar is linked to lower quality sleep," says Spencer. "In a clinical trial evaluating sugar's impact on sleep, those who consumed significant amounts of sugar had less time in deep, restorative slow-wave sleep. Those who ate more sugar also took longer to fall asleep."How can you fit sugar into a healthy diet?You don't need to totally forbid yourself from sugar."Although there are health risks of excess sugar, it is by no means a poison," says Heikkinen.In fact, totally cutting out sugar or forbidding yourself from having your favorite sweet treat may make you crave it even more, making it harder to control the portion when you do eat it."If you can limit sneaky sources of added sugar such as cereals, salad dressings, and granola bars, you can leave room in your budget for foods you really enjoy, such as a piece of chocolate," says Heikkinen.Aim for added sugar in moderation combined with mindful eating habits."Having sugary food every once in a while is okay! Moderation is key here. Zoom out to the big picture of your dietary habits, and look at 'how much and how often' are you having a sugar-sweetened food," says Spencer.She recommends a few easy ways to moderate your sugar intake.Read nutrition labels and keep sugar at less than 6 grams of added sugar per one serving of a packaged food item (this excludes fruit and plain dairy products).Pair foods with added sugar with protein, fat, and fiber to slow down digestion and enhance satiety. An example would be pairing a serving of sweetened granola with plain Greek yogurt and fiber-packed berries.And if you are struggling to manage sugar intake or feel out of control with sugar, another recommendation is to connect with a registered dietitian who can help you incorporate sugar in a healthful way. For help, check out these 20 Ways to End Sugar Cravings For Good, According to Nutritionists.For more healthy eating news, make sure to sign up for our newsletter!

Read this article:
In The Know Honors: Shereen Pimentel - Yahoo Canada Shine On

Posted in Anti-Aging Medicine | Comments Off on In The Know Honors: Shereen Pimentel – Yahoo Canada Shine On